← Country Explorer · Integrative Care Guide
MISSING SCRIPT / SOUTH AMERICA
Ecuador
Guayusa: living knowledge, caffeine and the limits of extrapolation.
Traditional use and preparation
Guayusa (Ilex guayusa) is a caffeinated leaf used in the Ecuadorian Amazon. A 2026 field study with Kichwa families documented cultivation, harvesting and preparation practices alongside knowledge of perceived benefits. This is evidence about a living tradition. It is not a clinical trial showing that a drink treats cancer.
A useful conversation should ask who grows and prepares it, how the practice is understood locally, and what knowledge people choose to share. Neither a country label nor a commercial tea label represents every community.
Human studies
A 2024 randomized, placebo-controlled crossover study tested single 600-mg and 1,200-mg doses of a guayusa leaf extract in young adults. The lower dose improved a short-term mood-disturbance score compared with placebo. The study also examined cognitive performance and cardiovascular measurements. It was an acute extract study, not a trial of everyday brewed tea, chronic illness or cancer-related fatigue.
Earlier research in 12 healthy men compared extracts supplying 200 mg caffeine with other caffeine sources. Studying caffeine absorption and short-term responses does not demonstrate that guayusa helps someone recover from chemotherapy. These research doses should not be used as personal dosing instructions.
Laboratory findings
A chemical analysis of guayusa leaves identified phenolic compounds and laboratory antioxidant activity, with differences after processing. That is interesting plant science. It does not establish absorption at an effective dose, tumor response, recurrence prevention or longer survival in people.
Evidence at a glance
- Human signal: short-term effects on mood and performance in healthy adults.
- Cancer evidence: the reviewed human studies do not establish treatment or symptom benefit in cancer patients.
- Safety: caffeine can affect sleep, heart rate and blood pressure. Concentrated extracts and stimulant blends may deliver amounts unlike a traditional infusion.
Care-team question: Could this worsen insomnia or palpitations, and is fatigue being evaluated for anemia, nutrition, sleep or treatment effects before adding a stimulant?
Community perspectives
What do local practitioners and community members want outsiders to understand? Who decides what can be recorded, and how should knowledge holders be credited and compensated? Which preparation is being discussed, and what outcome would count as a meaningful benefit?
These are research questions for future conversations, not a report of a visit. Traditional knowledge deserves careful attribution and consent; laboratory findings and clinical benefit remain separate questions.
Reviewed October 24, 2026. Educational, selective evidence review; not a treatment recommendation.
